LaSalle, Canada

James Edward Draper

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by James Edward Draper

Introduction

James Edward Draper is a notable inventor based in LaSalle, California. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of multi-phase soft gelatin dosage forms. With a total of three patents to his name, Draper's work focuses on combining solid and liquid phases for effective drug delivery.

Latest Patents

Draper's latest patents include innovative formulations that enhance the encapsulation of statins and omega-3 fatty acids. One of his patents describes a multi-phase soft gelatin dosage form that comprises at least one preformed solid dosage form containing a statin compound, along with a liquid fill phase containing omega-3 fatty acids. This invention is particularly useful for combining solid and liquid forms for single ingestion. Another patent outlines the method and apparatus for manufacturing these multi-phase soft gelatin dosage forms, emphasizing the potential for including active pharmaceutical ingredients, nutraceuticals, and other therapeutic substances.

Career Highlights

James Edward Draper is currently associated with Catalent Ontario Limited, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the technology behind soft gelatin capsules, making them more effective for patient use.

Collaborations

Draper has collaborated with notable colleagues such as Peter Robert Draper and Beth Okutan, contributing to a dynamic work environment that fosters innovation and creativity.

Conclusion

James Edward Draper stands out as a significant figure in the field of pharmaceutical inventions. His innovative patents and contributions to multi-phase soft gelatin dosage forms reflect his commitment to improving drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…